Clinical Trial Detail

NCT ID NCT03834740
Title Ph0/2 Ribociclib & Everolimus
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors St. Joseph's Hospital and Medical Center, Phoenix
Indications

malignant glioma

Therapies

Ribociclib + Everolimus

Age Groups: senior adult

Additional content available in CKB BOOST